{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HDAC inhibitor", "N\u025b-acetyl lysine", "ZBG group", "analogues", "hybridization"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31312496", "DateRevised": {"Year": "2023", "Month": "10", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "06", "Day": "05"}], "Language": ["eng"], "ELocationID": ["190338", "10.1098/rsos.190338"], "Journal": {"ISSN": "2054-5703", "JournalIssue": {"Volume": "6", "Issue": "6", "PubDate": {"Year": "2019", "Month": "Jun"}}, "Title": "Royal Society open science", "ISOAbbreviation": "R Soc Open Sci"}, "ArticleTitle": "N <i><sup>\u025b</sup></i> -acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors.", "Pagination": {"StartPage": "190338", "MedlinePgn": "190338"}, "Abstract": {"AbstractText": ["HDAC inhibitors have been developed very rapidly in clinical trials and even in approvals for treating several cancers. However, there are few reported HDAC inhibitors designed from N <sup><i>\u025b</i></sup> -acetyl lysine. In the current study, we raised a novel design, which concerns N <sup><i>\u025b</i></sup> -acetyl lysine derivatives containing amide acetyl groups with the hybridization of ZBG groups as novel HDAC inhibitors."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Wang", "ForeName": "Fang", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Wang", "ForeName": "Chun", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Wang", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Zou", "ForeName": "Yefang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Chen", "ForeName": "Xiaoxue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Liu", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Basic Medicine, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Li", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Zhao", "ForeName": "Yonglong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": ["0000-0001-6884-6166"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang 550004, People's Republic of China."}], "LastName": "He", "ForeName": "Bin", "Initials": "B"}], "DataBankList": [{"DataBankName": "figshare", "AccessionNumberList": ["10.6084/m9.figshare.c.4510232"]}, {"DataBankName": "Dryad", "AccessionNumberList": ["10.5061/dryad.d1t59pp"]}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "R Soc Open Sci", "NlmUniqueID": "101647528", "ISSNLinking": "2054-5703"}, "CoiStatement": "We have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bernstein BE, Tong JK, Schreiber SL. 2000. Genomewide studies of histone deacetylase function in yeast. Proc. Natl Acad. Sci. USA 97, 13 708\u201313 713. (10.1073/pnas.250477697)", "ArticleIdList": ["10.1073/pnas.250477697", "PMC17640", "11095743"]}, {"Citation": "De Ruijter AJM, Van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. 2003. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737\u2013749. (10.1042/bj20021321)", "ArticleIdList": ["10.1042/bj20021321", "PMC1223209", "12429021"]}, {"Citation": "Glozak MA, Sengupta N, Zhang X, Seto E. 2005. Acetylation and deacetylation of non-histone proteins. Gene 363, 15\u201323. (10.1016/j.gene.2005.09.010)", "ArticleIdList": ["10.1016/j.gene.2005.09.010", "16289629"]}, {"Citation": "Sangwan R, Rajan R, Mandal PK. 2018. HDAC as onco target: reviewing the synthetic approaches with SAR study of their inhibitors. Eur. J. Med. Chem. 158, 620\u2013706. (10.1016/j.ejmech.2018.08.073)", "ArticleIdList": ["10.1016/j.ejmech.2018.08.073", "30245394"]}, {"Citation": "Gregoretti I, Lee Y-M, Goodson HV. 2004. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338, 17\u201331. (10.1016/j.jmb.2004.02.006)", "ArticleIdList": ["10.1016/j.jmb.2004.02.006", "15050820"]}, {"Citation": "Haigis MC, Guarente LP. 2006. Mammalian sirtuins\u2013emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913\u20132921. (10.1101/gad.1467506)", "ArticleIdList": ["10.1101/gad.1467506", "17079682"]}, {"Citation": "Weichert W, Roske A, Gekeler V, Beckers T, Ebert MP, Pross M, Dietel M, Denkert C, Rocken C. 2008. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol. 9, 139\u2013148. (10.1016/S1470-2045(08)70004-4)", "ArticleIdList": ["10.1016/S1470-2045(08)70004-4", "18207460"]}, {"Citation": "Weichert W, et al. 2008. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. J. Cancer. 98, 604\u2013610. (10.1038/sj.bjc.6604199)", "ArticleIdList": ["10.1038/sj.bjc.6604199", "PMC2243142", "18212746"]}, {"Citation": "Sudo T, et al. 2011. Histone deacetylase 1 expression in gastric cancer. Oncol. Rep. 26, 777\u2013782. (10.3892/or.2011.1361)", "ArticleIdList": ["10.3892/or.2011.1361", "21725604"]}, {"Citation": "Oehme I, et al. 2009. Histone deacetylase 8 in neuroblastoma tumorigenesis. Clin. Cancer Res. 15, 91\u201399. (10.1158/1078-0432.CCR-08-0684)", "ArticleIdList": ["10.1158/1078-0432.CCR-08-0684", "19118036"]}, {"Citation": "West AC, Johnstone. 2014. New and emerging HDAC inhibitors for cancer treatment. J. Clin. Invest. 124, 30\u201339. (10.1172/JCI69738)", "ArticleIdList": ["10.1172/JCI69738", "PMC3871231", "24382387"]}, {"Citation": "Falkenberg KJ, Johnstone RW. 2014. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 13, 673\u2013691. (10.1038/nrd4360)", "ArticleIdList": ["10.1038/nrd4360", "25131830"]}, {"Citation": "Li Y, Seto E. 2016. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb. Perspect. Med. 6, a026831 (10.1101/cshperspect.a026831)", "ArticleIdList": ["10.1101/cshperspect.a026831", "PMC5046688", "27599530"]}, {"Citation": "Duvic M, et al. 2007. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 109, 31\u201339. (10.1182/blood-2006-06-025999)", "ArticleIdList": ["10.1182/blood-2006-06-025999", "PMC1785068", "16960145"]}, {"Citation": "Piekarz RL, et al. 2009. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J. Clin. Oncol. 27, 5410\u20135417. (10.1200/JCO.2008.21.6150)", "ArticleIdList": ["10.1200/JCO.2008.21.6150", "PMC2773225", "19826128"]}, {"Citation": "Molife LR, de Bono JS. 2011. Belinostat: clinical applications in solid tumors and lymphoma. Expert Opin. Investig. Drugs. 20, 1723\u20131732. (10.1517/13543784.2011.629604)", "ArticleIdList": ["10.1517/13543784.2011.629604", "22046971"]}, {"Citation": "Libby EN, Becker PS, Burwick N, Green DJ, Holmberg L, Bensinger WI. 2015. Panobinostat: a review of trial results and future prospects in multiple myeloma. Expert Rev. Hematol. 8, 9\u201318. (10.1586/17474086.2015.983065)", "ArticleIdList": ["10.1586/17474086.2015.983065", "25410127"]}, {"Citation": "Li Y, et al. 2015. A new strategy to target acute myeloid leukemia stem and progenitor cells using chidamide, a histone deacetylase inhibitor. Curr. Cancer Drug Targets 15, 493\u2013503. (10.2174/156800961506150805153230)", "ArticleIdList": ["10.2174/156800961506150805153230", "26282548"]}, {"Citation": "Zhang L, et al. 2015. Trend of histone deacetylase inhibitors in cancer therapy: isoform selectivity or multitargeted strategy. Med. Res. Rev. 35, 63\u201384. (10.1002/med.21320)", "ArticleIdList": ["10.1002/med.21320", "24782318"]}, {"Citation": "Frey RR, et al. 2002. Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorg. Med. Chem. Lett. 12, 3443\u20133447. (10.1016/S0960-894X(02)00754-0)", "ArticleIdList": ["10.1016/S0960-894X(02)00754-0", "12419380"]}, {"Citation": "Reiter LA, et al. 2004. Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1. Bioorg. Med. Chem. Lett. 14, 3389\u20133395. (10.1016/j.bmcl.2004.04.083)", "ArticleIdList": ["10.1016/j.bmcl.2004.04.083", "15177439"]}, {"Citation": "Farkas E, Katz Y, Bhusare S, Reich R, R\u00f6schenthaler GV, K\u00f6nigsmann M, Breuer E. 2004. Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group. J. Biol. Inorg. Chem. 9, 307\u2013315. (10.1007/s00775-004-0524-5)", "ArticleIdList": ["10.1007/s00775-004-0524-5", "14762707"]}, {"Citation": "O'Brien EC, Farkas E, Gil MJ, Fitzgerald D, Castineras A, Nolan KB. 2000. Metal complexes of salicylhydroxamic acid (H2Sha), anthranilic hydroxamic acid and benzohydroxamic acid. Crystal and molecular structure of [Cu(phen)2(Cl)]Cl\u00b7H2Sha, a model for a peroxidase-inhibitor complex. J. Inorg. Biochem. 79, 47\u201351. (10.1016/S0162-0134(99)00245-7)", "ArticleIdList": ["10.1016/S0162-0134(99)00245-7", "10830846"]}, {"Citation": "Li Y, Woster PM. 2015. Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding group. Medchemcomm. 6, 613\u2013618. (10.1039/C4MD00401A)", "ArticleIdList": ["10.1039/C4MD00401A", "PMC4440699", "26005563"]}, {"Citation": "Clawson GA. 2016. Histone deacetylase inhibitors as cancer therapeutics. Ann. Transl. Med. 4, 287 (10.21037/atm.2016.07.22)", "ArticleIdList": ["10.21037/atm.2016.07.22", "PMC4980376", "27568481"]}, {"Citation": "Suzuki T, Miyata N. 2005. Non-hydroxamate histone deacetylase inhibitors. Curr. Med. Chem. 12, 2867\u20132880. (10.2174/092986705774454706)", "ArticleIdList": ["10.2174/092986705774454706", "16305476"]}, {"Citation": "Dancy BC, et al. 2012. Azalysine analogues as probes for protein lysine deacetylation and demethylation. J. Am. Chem. Soc. 134, 5138\u20135148. (10.1021/ja209574z)", "ArticleIdList": ["10.1021/ja209574z", "PMC3313494", "22352831"]}, {"Citation": "Smith BC, Denu JM. 2007. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases. J. Biol. Chem. 282, 37 256\u201337 265. (10.1074/jbc.M707878200)", "ArticleIdList": ["10.1074/jbc.M707878200", "17951578"]}, {"Citation": "Hu J, Jing H, Lin H. 2014. Sirtuin inhibitors as anticancer agents. Future Med. Chem. 6, 945\u2013966. (10.4155/fmc.14.44)", "ArticleIdList": ["10.4155/fmc.14.44", "PMC4384657", "24962284"]}, {"Citation": "Chen B, Zang W, Wang J, Huang Y, He Y, Yan L, Liu J, Zheng W. 2015. The chemical biology of sirtuins. Chem. Soc. Rev. 44, 5246\u20135264. (10.1039/C4CS00373J)", "ArticleIdList": ["10.1039/C4CS00373J", "25955411"]}, {"Citation": "He B, Du J, Lin H. 2012. Thiosuccinyl peptides as Sirt5-specific inhibitors. J. Am. Chem. Soc. 134, 1922\u20131925. (10.1021/ja2090417)", "ArticleIdList": ["10.1021/ja2090417", "PMC3271735", "22263694"]}, {"Citation": "He B, Hu J, Zhang X, Lin H. 2014. Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors. Org. Biomol. Chem. 12, 7498\u20137502. (10.1039/C4OB00860J)", "ArticleIdList": ["10.1039/C4OB00860J", "PMC4161628", "25163004"]}, {"Citation": "Jing H, et al. 2016. A SIRT2-selective inhibitor promotes c-myc oncoprotein degradation and exhibits broad anticancer activity. Cancer Cell. 29, 297\u2013310. (10.1016/j.ccell.2016.02.007)", "ArticleIdList": ["10.1016/j.ccell.2016.02.007", "PMC4811675", "26977881"]}, {"Citation": "Wang C, et al. 2018. The mimics of N \u025b -acyl-lysine derived from cysteine as sirtuin inhibitors. Bioorg. Med. Chem. Lett., 28, 2375\u20132378. (10.1016/j.bmcl.2018.06.030)", "ArticleIdList": ["10.1016/j.bmcl.2018.06.030", "29921476"]}, {"Citation": "Wang F, Wang C, Wang J, Zou Y, Chen X, Liu T, Li Y, Zhao Y, Li Y, He B. 2019. Data from: N\u025b-acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors Dryad Digital Repository. (10.5061/dryad.d1t59pp)", "ArticleIdList": ["10.5061/dryad.d1t59pp", "PMC6599804", "31312496"]}]}], "History": [{"Year": "2019", "Month": "2", "Day": "27"}, {"Year": "2019", "Month": "4", "Day": "30"}, {"Year": "2019", "Month": "7", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "18", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "6", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["31312496", "PMC6599804", "10.1098/rsos.190338", "rsos190338"]}}]}